Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands-Reference-Cited by-同舟云学术

Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands

Published:2018-07-16 Issue:2 Volume:5 Page:127-135
ISSN:2058-5225
Container-title:European Heart Journal - Quality of Care and Clinical Outcomes
language:en
Short-container-title:

Author:

Bennaghmouch Naoual¹,de Veer Anne J W M¹,Mahmoodi Bakhtawar K¹,Jofre-Bonet Mireia²,Lip Gregory Y H³,Bode Kerstin⁴,ten Berg Jurriën M¹

Affiliation:

1. Department of Cardiology, St. Antonius Hospital, Koekoekslaan 1, CM Nieuwegein, the Netherlands

2. Department of Economics, City University of London, Northampton Square, London, UK

3. Institute of Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, UK

4. Heart Center, University of Leipzig, Strümpellstraße 39, Leipzig, Germany

Funder

St. Antonius Hospital Research Fund

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Health Policy

Link

http://academic.oup.com/ehjqcco/article-pdf/5/2/127/28245660/qcy030.pdf

Reference44 articles.

1. Association between bleeding events and in-hospital mortality after percutaneous coronary intervention;Chhatriwalla;JAMA,2013

2. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study;Lamberts;Circulation,2012

3. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score;Smith;EuroIntervention,2012

4. Intensifying platelet inhibition–navigating between Scylla and Charybdis;Bhatt;N Engl J Med,2007

5. When is a double better than a triple? Stenting in patients with atrial fibrillation;Bhatt;J Am Coll Cardiol,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain;PLOS ONE;2022-04-20

2. Obstructive Sleep Apnea and Atrial Fibrillation;Journal of Clinical Medicine;2022-02-25

3. Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France;PLOS ONE;2020-01-24